{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:12:43Z","timestamp":1760242363584},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.humpath.2008.02.016","type":"journal-article","created":{"date-parts":[[2008,7,14]],"date-time":"2008-07-14T19:02:50Z","timestamp":1216062170000},"page":"1505-1510","source":"Crossref","is-referenced-by-count":16,"title":["Expression of p63 in anaplastic large cell lymphoma but not in classical Hodgkin's lymphoma"],"prefix":"10.1016","volume":"39","author":[{"given":"Gabriela","family":"Gualco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence M.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Bacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2008.02.016_bib1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4161\/cc.6.3.3793","article-title":"The roles of p63 in cancer","volume":"6","author":"Flores","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2008.02.016_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.pai.0000142160.52670.ce","article-title":"Expression of p63 in diffuse large B-cell lymphoma","volume":"13","author":"Hedvat","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2008.02.016_bib3","first-page":"494","article-title":"p63 expression profiles in human normal and tumor tissues","volume":"8","author":"Di Como","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2008.02.016_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/path.1231","article-title":"Differential expression of p63 isoforms in normal tissues and neoplastic cells","volume":"198","author":"Nylander","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2008.02.016_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0301-472X(00)00326-X","article-title":"Mutation of P51A\/TAP63 g gene is associated with blastic crisis in chronic myeloid leukemia","volume":"28","author":"Yamaguchi","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.humpath.2008.02.016_bib6","first-page":"898","article-title":"p53 and hematologic malignancies","volume":"45","author":"Preudhomme","year":"1997","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.humpath.2008.02.016_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4161\/cc.6.3.3802","article-title":"Hitting the numbers: the emerging network of p63 targets","volume":"6","author":"Vigano","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2008.02.016_bib8","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4161\/cc.6.9.4162","article-title":"p63: the phantom of the tumor suppressor","volume":"6","author":"Finlan","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2008.02.016_bib9","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"230","year":"2001"},{"key":"10.1016\/j.humpath.2008.02.016_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.pas.0000179123.66748.c2","article-title":"ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's disease","volume":"30","author":"Vassallo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2008.02.016_bib11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1309\/R2Q9CCUVTLRYCF3H","article-title":"Anaplastic large cell lymphoma","volume":"127","author":"Medeiros","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2008.02.016_bib12","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1080\/10428190701342000","article-title":"Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma","volume":"48","author":"Tamaru","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2008.02.016_bib13","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.bloodjournal664848","article-title":"The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2008.02.016_bib14","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3346\/jkms.2005.20.5.752","article-title":"Expression of p63 in reactive hyperplasias and malignant lymphomas","volume":"20","author":"Park Ch","year":"2005","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.humpath.2008.02.016_bib15","first-page":"596","article-title":"Common features and differences in the trancriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma","volume":"91","author":"Willenbrock","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2008.02.016_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1309\/GQ2RLNDWLB9WY6UU","article-title":"Clusterin, a marker for anaplastic large cell lymphoma","volume":"121","author":"Nascimento","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2008.02.016_bib17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/01.MP.0000036386.87517.AA","article-title":"Clusterin expression in malignant lymphomas: a survey of 266 cases","volume":"15","author":"Saffer","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2008.02.016_bib18","first-page":"543","article-title":"Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's disease. Evidence for a dendritic or B cell derivation?","volume":"150","author":"Pinkus","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2008.02.016_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1309\/EAE3TGPP4A5RVA92","article-title":"Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease","volume":"119","author":"Fan","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2008.02.016_bib20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.5858\/2007-131-742-FEIDLB","article-title":"Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma","volume":"131","author":"Bakshi","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2008.02.016_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/jcp.2006.039917","article-title":"Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis","volume":"60","author":"Mhawech-Fauceglia","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2008.02.016_bib22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/modpathol.3800622","article-title":"Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays","volume":"19","author":"McCune","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2008.02.016_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1097-2765(00)80275-0","article-title":"p63 and p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities","volume":"2","author":"Yang","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.humpath.2008.02.016_bib24","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0002-9440(10)64396-9","article-title":"Loss of p63 expression is associated with tumor progression in bladder cancer","volume":"161","author":"Urist","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2008.02.016_bib25","first-page":"7113","article-title":"Significance of p63 amplification and overexpression in lung cancer development and prognosis","volume":"63","author":"Massion","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2008.02.016_bib26","first-page":"3352","article-title":"Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5\u00a2 CpG island methylation","volume":"59","author":"Corn","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2008.02.016_bib27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1023\/A:1011153206003","article-title":"Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia","volume":"12","author":"Novak","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2008.02.016_bib28","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.urology.2004.01.009","article-title":"Prognostic impact of p63 and p53 in upper urinary tract transitional cell carcinoma","volume":"63","author":"Zigeuner","year":"2004","journal-title":"Urology"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817708001159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817708001159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T03:47:57Z","timestamp":1631504877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817708001159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0046817708001159"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2008.02.016","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}